Mexidol not checked

Pharmasoft

FollowEvery change as it happens, and a Monday email
Stage
in other
Next date
Phase 4 trial completes
Trials
1 active
9 in total
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
How it’s given
“Phase 1 (Days 1-10): Mexidol® solution, 500 mg (10 ml) twice daily (total daily dose 1000 mg) administered via IV infusion in 100-200 ml of 0.9% NaCl solution for 10 days. Infusion rate: 40-60 drops per minute. Phase 2 (Days 11-70): Mexidol® FORTE 250 film-coated tablets, 250 mg three times daily (total daily dose 750 mg) for 60 days. Administered on top of standard background therapy in…”In the company’s words, NCT07575984 on ClinicalTrials.gov
Tested for
Ischemic Stroke
Main trialPhase 4
“The primary objective of this study is to further define the mechanisms of action of Mexidol® (solution for intravenous and intramuscular injection, 50 mg/ml) and Mexidol® FORTE 250 (film-coated tablets, 250 mg) in the hyperacute and acute periods of ischemic stroke, and to evaluate their impact on clinical and neuroimaging outcomes of the disease.”In the company’s words, NCT07575984 on ClinicalTrials.gov
Other names
Ethylmethylhydroxypyridine Succinate

Other drugs for Ischemic Stroke

All 45 drugs for Ischemic Stroke

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials9

TrialPhaseCompletesWhat it tests
Phase 4Recruiting Apr 2027 Mexidol® Safety and Efficacy in Treatment of Hyperacute and Acute Ischemic Stroke
Phase 4Completed 12 Sep 2023 MEXIDOL® in the Rehabilitation Treatment of Patients With Acute Cerebral Failure
Phase 4Completed 29 Nov 2023 MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG)
Phase 4Completed 5 Nov 2025 Mexidol® Efficacy and Safety in Treatment of VCIND in Older Adults
Phase 3Completed 27 May 2016 Study of Efficacy and Safety of MEXIDOL® in Ischemic Stroke Therapy
Phase 3Completed 13 Jul 2020 Safety and Efficacy of Mexidol® for ADHD in Children Aged 6-12
Phase 3Completed 8 Dec 2020 Safety and Efficacy of Sequential Therapy With Mexidol® in Patients With Chronic Cerebral Ischemia
Phase 3Completed 18 Aug 2023 Efficacy and Safety of Mexidol® in Stroke Therapy
Phase 2Completed 7 Sep 2023 Efficacy and Safety of Different Dosages of Mexidol® in Patients With Primary Open-angle Glaucoma (POAG)
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Mexidol

Following is part of Solo: you see every change to Mexidol the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in